{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T11:40:06Z","timestamp":1736941206667,"version":"3.33.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","advancesradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.adro.2024.101663","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T13:48:23Z","timestamp":1730209703000},"page":"101663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pegylated Interferon Combined With Low-Dose Total Skin Electron Beam Therapy for Advanced Stage Mycosis Fungoides: Two Case Reports and Literature Review"],"prefix":"10.1016","volume":"10","author":[{"given":"Khaled","family":"Elsayad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Theodor","family":"Eich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2024.101663_bib0001","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000475634","article-title":"Total skin electron beam therapy as part of multimodal treatment strategies for primary cutaneous T-cell lymphoma","volume":"40","author":"Elsayad","year":"2017","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.adro.2024.101663_bib0002","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijrobp.2023.02.052","article-title":"Ultra-hypofractionated low-dose total skin electron beam in advanced stage mycosis fungoides and S\u00e9zary syndrome","volume":"117","author":"Elsayad","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101663_bib0003","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaad.2014.10.014","article-title":"Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials","volume":"72","author":"Hoppe","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adro.2024.101663_bib0004","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","article-title":"Modern radiation therapy for primary cutaneous lymphomas: Field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Specht","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101663_bib0005","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2015.01.047","article-title":"Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: An open clinical study and pooled data analysis","volume":"92","author":"Kamstrup","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101663_bib0006","first-page":"279","article-title":"Low-dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T-cell lymphoma","volume":"20","author":"Elsayad","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.adro.2024.101663_bib0007","article-title":"Low-dose total skin electron beam therapy combined with mogamulizumab for refractory mycosis fungoides and S\u00e9zary syndrome","volume":"6","author":"Fong","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2024.101663_bib0008","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/bjd\/ljac012","article-title":"Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma","volume":"188","author":"Oymanns","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adro.2024.101663_bib41","doi-asserted-by":"crossref","first-page":"115064","DOI":"10.1016\/j.ejca.2024.115064","article-title":"Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group","volume":"212","author":"Elsayad","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2024.101663_bib0009","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0889-8588(18)30060-1","article-title":"Interferon in the treatment of cutaneous T-cell lymphoma","volume":"9","author":"Olsen","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.adro.2024.101663_bib0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.det.2015.05.008","article-title":"The use of interferons in the treatment of cutaneous T-cell lymphoma","volume":"33","author":"Spaccarelli","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.adro.2024.101663_bib0011","doi-asserted-by":"crossref","first-page":"adv10306","DOI":"10.2340\/actadv.v103.10306","article-title":"Use of pegylated interferon alpha-2a in cutaneous T-cell lymphoma: A retrospective case collection","volume":"103","author":"Gosmann","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.adro.2024.101663_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113343","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome \u2013 Update 2023","volume":"195","author":"Latzka","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2024.101663_bib0013","first-page":"3578","article-title":"Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II","volume":"92","author":"Stadler","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.adro.2024.101663_bib0014","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/bjd.12386","article-title":"Mycosis fungoides: The addition of concurrent and adjuvant interferon to total skin electron beam therapy","volume":"169","author":"Wagner","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adro.2024.101663_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2133.2006.07559.x","article-title":"Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?","volume":"156","author":"Roberge","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adro.2024.101663_bib0016","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.adro.2024.101663_bib0017","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1339857","article-title":"TREX1 dictates the immune fate of irradiated cancer cells","volume":"6","author":"Vanpouille-Box","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.adro.2024.101663_bib0018","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.adro.2024.101663_bib0019","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0959-8049(21)00723-1","article-title":"Pegylated-interferon as an alternative to interferon-alfa 2a in cutaneous T-cell lymphoma","volume":"156","author":"Iype","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2024.101663_bib0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/bjd\/ljae152","article-title":"Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides\/S\u00e9zary syndrome using time to next treatment as a measure of clinical benefit: An EORTC CLTG study","volume":"191","author":"Mitsunaga","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adro.2024.101663_bib0021","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918768240","article-title":"Radiotherapy and checkpoint inhibitors: A winning new combination?","volume":"10","author":"Ko","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.adro.2024.101663_bib0022","first-page":"3","article-title":"Pembrolizumab in systemic and cutaneous T-cell lymphoma","volume":"2","author":"Dai","year":"2018","journal-title":"Ann Lymphoma"},{"key":"10.1016\/j.adro.2024.101663_bib0023","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaad.2020.01.046","article-title":"A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life","volume":"83","author":"Song","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adro.2024.101663_bib0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijrobp.2020.02.016","article-title":"Combining radiation therapy with interferons: Back to the future","volume":"108","author":"Goedegebuure","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101663_bib0025","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.2018888107","article-title":"Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma","volume":"134","author":"Lindahl","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.adro.2024.101663_bib0026","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/eji.202049043","article-title":"CCR4 in cutaneous T-cell lymphoma: Therapeutic targeting of a pathogenic driver","volume":"51","author":"Nicolay","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.adro.2024.101663_bib0027","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","article-title":"The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity","volume":"71","author":"Burnette","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.adro.2024.101663_bib0028","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrclinonc.2016.183","article-title":"Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy","volume":"14","author":"Galluzzi","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.adro.2024.101663_bib0029","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41590-020-0751-0","article-title":"Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.adro.2024.101663_bib0030","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.adro.2024.101663_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.680503","article-title":"Radiation-induced immunity and toxicities: The versatility of the cGAS-STING pathway","volume":"12","author":"Constanzo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.adro.2024.101663_bib0032","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1089\/ars.2017.7267","article-title":"Targeted and off-target (bystander and abscopal) effects of radiation therapy: Redox mechanisms and risk\/benefit analysis","volume":"29","author":"Pouget","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.adro.2024.101663_bib0033","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fonc.2012.00191","article-title":"Radiation-induced effects and the immune system in cancer","volume":"2","author":"Kaur","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2024.101663_bib0034","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.adro.2024.101663_bib0035","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101663_bib0036","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","article-title":"Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy","volume":"12","author":"Herrera","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.adro.2024.101663_bib0037","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2011.09.049","article-title":"Maximizing tumor immunity with fractionated radiation","volume":"83","author":"Schaue","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101663_bib0038","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ijrobp.2017.05.052","article-title":"The results of low-dose total skin electron beam radiation therapy (TSEB) in patients with mycosis fungoides from the UK Cutaneous Lymphoma Group","volume":"99","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101663_bib0039","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ijrobp.2007.11.039","article-title":"A prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides","volume":"71","author":"Kamstrup","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101663_bib0040","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3390\/cancers12082311","article-title":"Time to next treatment as a meaningful endpoint for trials of primary cutaneous lymphoma","volume":"12","author":"Campbell","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.adro.2024.101663_bib42","article-title":"Pegylated interferon-\u03b12a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patients","volume":"2","author":"Hansen-Abeck","year":"2024","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109424002264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109424002264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T10:10:17Z","timestamp":1736849417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109424002264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2452109424002264"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2024.101663","relation":{},"ISSN":["2452-1094"],"issn-type":[{"type":"print","value":"2452-1094"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pegylated Interferon Combined With Low-Dose Total Skin Electron Beam Therapy for Advanced Stage Mycosis Fungoides: Two Case Reports and Literature Review","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2024.101663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101663"}}